IC-ONC Global

Connect with a network of local and national thought leaders and clinicians responsible for treating patients with cancer. Likes/RT≠endorsement

[IC-ONC Global @IC_ONC]

NEW CME ACTIVITY!
2 Multidisciplinary tumor boards discuss patient cases in melanoma/NSCLC & bladder/renal cell cancers. Strategies for ensuring patients receiving immunotherapy receive effective, timely, equitable biomarker testing, dx, tx & followup. https://t.co/yRMnmPMBen

[The ASCO Post @ASCOPost]

KEYNOTE-A18: Overall Survival in Cervical Cancer Improved by Pembrolizumab Plus Chemoradiotherapy https://t.co/r1GMyFKZvN #gyncsm #cervicalcancer #immunotherapy #oncology

[Yüksel Ürün @DrYukselUrun]

Fusobacterium nucleatum (Fn) makes resistant microsatellite stable colorectal cancer respond better to anti-PD-1 therapy by boosting CD8+ T-cell function. High Fn levels could predict better outcomes with immunotherapy. #ColorectalCancer #Immunotherapy #Oncology @OncoAlert @Cancer_Cell
DOI: 10.1016/j.ccell.2024.08.019

[IC-ONC Global @IC_ONC]

The hallmarks of cancer immune evasion: Cancer Cell https://t.co/26JOrlEzHQ

[IC-ONC Global @IC_ONC]

NEW CME ACTIVITY!
2 Multidisciplinary tumor boards discuss patient cases in melanoma/NSCLC & bladder/renal cell cancers. Strategies for ensuring patients receiving immunotherapy receive effective, timely, equitable biomarker testing, dx, tx & followup. https://t.co/yRMnmPMBen

[IC-ONC Global @IC_ONC]

NEW CME ACTIVITY!
2 Multidisciplinary tumor boards discuss patient cases in melanoma/NSCLC & bladder/renal cell cancers. Strategies for ensuring patients receiving immunotherapy receive effective, timely, equitable biomarker testing, dx, tx & followup. https://t.co/yRMnmPMBen

[Jason Luke, MD, FACP, FASCO @jasonlukemd]

Thanks @AACR for the profile. Hope all #immunotherapy & #immunology interested folks will join the Cancer Immunology Working Group (CIMM), particularly on LinkedIn for on-going discussions of the field!

[NEJM @NEJM]

Adjuvant pembrolizumab was approved for patients with renal-cell carcinoma on the basis of improvements in disease-free survival observed in the KEYNOTE-564 trial. Data on overall survival are needed. Research findings are summarized in a Quick Take video: https://t.co/IX53o1IMrB

[IC-ONC Global @IC_ONC]

@ASCP @UVaCME & Society of Black Pathologists present 2 Multidisciplinary tumor boards in Melanoma/NSCLC and Bladder/Renal Cell cancers. Strategies for ensuring patients receiving I-O Therapy receive effective, timely, equitable testing, dx, tx & followup https://t.co/yRMnmPMBen

[IC-ONC Global @IC_ONC]

NEW CE ACTIVITY! https://t.co/yRMnmPMBen
2 Multidisciplinary tumor boards in melanoma/NSCLC & bladder/renal cell cancers. Strategies for ensuring patients receiving immunotherapy receive effective, timely, equitable biomarker testing, dx, tx & followup. @ASCP_Chicago @UVaCME

[IC-ONC Global @IC_ONC]

NEW CME ACTIVITY!
2 Multidisciplinary tumor boards discuss patient cases in melanoma, NSCLC, bladder & renal cell cancers. Strategies for ensuring patients receiving immunotherapy receive effective, timely, equitable biomarker testing, dx, tx & followup. https://t.co/yRMnmPN93V

[IC-ONC Global @IC_ONC]

NEW CME ACTIVITY! 2 Multidisciplinary tumor boards discuss patient cases in melanoma, NSCLC, bladder & renal cell cancers. Strategies for ensuring patients receiving immunotherapy receive effective, timely, equitable biomarker testing, dx, tx & followup. https://t.co/yRMnmPMBen

[ASCP @ASCP_Chicago]

Join us on January 18 for IC-ONC Annual Forum & participate in a case-based webinar designed to help cancer care teams stay up to date on advances in renal cell carcinoma & bladder cancer. Learn more & register now: https://t.co/xAENEKKqAL

#SBP #SocietyOfBlackPathologists

[IC-ONC Global @IC_ONC]

The University of Virginia, @ASCP_Chicago & SBP are pleased to present the 2024 IC-ONC Annual Forum: A Series of Case Based Webinars

January 18, Registration and more info: https://t.co/mAXRAX1iTW

Register soon to hold your spot!

[IC-ONC Global @IC_ONC]

🔥Todays the day @ noon eastern!
2024 IC-ONC Annual Forum: A Series of Case Based Webinars; Presented by The University of Virginia, @ASCP_Chicago & SBP
See you then!

🎟️There is still time to register!
December 8: https://t.co/6F6KNsWhnn
January 18: https://t.co/mAXRAX1iTW

[IC-ONC Global @IC_ONC]

🔥Todays the day @ noon eastern!
2024 IC-ONC Annual Forum: A Series of Case Based Webinars; Presented by The University of Virginia, @ASCP_Chicago & SBP
See you then!

🎟️There is still time to register!
December 8: https://t.co/6F6KNsWhnn
January 18: https://t.co/mAXRAX1iTW

[IC-ONC Global @IC_ONC]

The University of Virginia, @ASCP_Chicago & SBP are pleased to present the 2024 IC-ONC Annual Forum: A Series of Case Based Webinars

Register soon to hold your spot!
December 8 Register: https://t.co/6F6KNsWhnn
January 18 Register: https://t.co/mAXRAX1iTW
@UVaCME

[IC-ONC Global @IC_ONC]

The University of Virginia, @ASCP_Chicago & SBP are pleased to present the 2024 IC-ONC Annual Forum: A Series of Case Based Webinars

Register soon to hold your spot!
December 8 Register: https://t.co/6F6KNsWhnn
January 18 Register: https://t.co/mAXRAX1iTW

@UVaCME

[ASCP @ASCP_Chicago]

Join us on December 8 for IC-ONC Annual Forum, where you will participate in a case-based webinar designed to help multidisciplinary cancer care teams stay updated on advances in melanoma & NSCLC. Learn more & register now: https://t.co/zayKhuW7Vp #SBP #SocietyOfBlackPathologists

[IC-ONC Global @IC_ONC]

The University of Virginia, @ASCP_Chicago & SBP are pleased to present the 2024 IC-ONC Annual Forum: A Series of Case Based Webinars
Register soon to hold your spot!
December 8 Register: https://t.co/6F6KNsWhnn
January 18 Register: https://t.co/mAXRAX1iTW
@UVaCME